Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway - PubMed (original) (raw)
. 2013 Jun;34(6):1331-42.
doi: 10.1093/carcin/bgt060. Epub 2013 Feb 7.
Affiliations
- PMID: 23393227
- DOI: 10.1093/carcin/bgt060
Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway
Dong-Mei Zhang et al. Carcinogenesis. 2013 Jun.
Abstract
Hepatocellular carcinoma (HCC) is a deadly form of cancer without effective chemotherapy so far. Currently, only sorafenib, a multitargeted tyrosine kinase inhibitor, slightly improves survival in HCC patients. In searching for natural anti-HCC components from toad venom, which is frequently used in the treatment of liver cancer in traditional Chinese medicine, we discovered that arenobufagin, a bufadienolide from toad venom, had potent antineoplastic activity against HCC HepG2 cells as well as corresponding multidrug-resistant HepG2/ADM cells. We found that arenobufagin induced mitochondria-mediated apoptosis in HCC cells, with decreasing mitochondrial potential, as well as increasing Bax/Bcl-2 expression ratio, Bax translocation from cytosol to mitochondria. Arenobufagin also induced autophagy in HepG2/ADM cells. Autophagy-specific inhibitors (3-methyladenine, chloroquine and bafilomycin A1) or Beclin1 and Atg 5 small interfering RNAs (siRNAs) enhanced arenobufagin-induced apoptosis, indicating that arenobufagin-mediated autophagy may protect HepG2/ADM cells from undergoing apoptotic cell death. In addition, we observed the inhibition of phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway by arenobufagin. Interestingly, inhibition of mTOR by rapamycin or siRNA duplexes augmented arenobufagin-induced apoptosis and autophagy. Finally, arenobufagin inhibited the growth of HepG2/ADM xenograft tumors, which were associated with poly (ADP-ribose) polymerase cleavage, light chain 3-II activation and mTOR inhibition. In summary, we first demonstrated the antineoplastic effect of arenobufagin on HCC cells both in vitro and in vivo. We elucidated the underlying antineoplastic mechanisms of arenobufagin that involve cross talk between apoptosis and autophagy via inhibition of the PI3K/Akt/mTOR pathway. This study may provide a rationale for future clinical application using arenobufagin as a chemotherapeutic agent for HCC.
Similar articles
- Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
Yang J, Pi C, Wang G. Yang J, et al. Biomed Pharmacother. 2018 Jul;103:699-707. doi: 10.1016/j.biopha.2018.04.072. Epub 2018 Apr 24. Biomed Pharmacother. 2018. PMID: 29680738 - Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F, Mao Y, You Q, Hua D, Cai D. Wang F, et al. Int J Immunopathol Pharmacol. 2015 Sep;28(3):362-73. doi: 10.1177/0394632015598849. Epub 2015 Aug 5. Int J Immunopathol Pharmacol. 2015. PMID: 26246196 - 1β-OH-arenobufagin induces mitochondrial apoptosis in hepatocellular carcinoma through the suppression of mTOR signaling pathway.
Deng LJ, Lei YH, Quan JY, Li BJ, Zhang DM, Tian HY, Chen Y, Zhang EX, Chen L, Ye WC, Ning WM, Yu LZ, Liu JS. Deng LJ, et al. J Ethnopharmacol. 2021 Feb 10;266:113443. doi: 10.1016/j.jep.2020.113443. Epub 2020 Oct 3. J Ethnopharmacol. 2021. PMID: 33022344 - [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].
Longerich T. Longerich T. Pathologe. 2014 Nov;35 Suppl 2:177-84. doi: 10.1007/s00292-014-2007-y. Pathologe. 2014. PMID: 25394965 Review. German. - Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer.
Sokolowski KM, Koprowski S, Kunnimalaiyaan S, Balamurugan M, Gamblin TC, Kunnimalaiyaan M. Sokolowski KM, et al. Anticancer Agents Med Chem. 2016;16(1):29-37. doi: 10.2174/1871520615666150716104408. Anticancer Agents Med Chem. 2016. PMID: 26179270 Review.
Cited by
- Elaborating the role of natural products-induced autophagy in cancer treatment: achievements and artifacts in the state of the art.
Wang N, Feng Y. Wang N, et al. Biomed Res Int. 2015;2015:934207. doi: 10.1155/2015/934207. Epub 2015 Mar 3. Biomed Res Int. 2015. PMID: 25821829 Free PMC article. Review. - New insights into autophagy in hepatocellular carcinoma: mechanisms and therapeutic strategies.
Yang S, Yang L, Li X, Li B, Li Y, Zhang X, Ma Y, Peng X, Jin H, Li H. Yang S, et al. Am J Cancer Res. 2019 Jul 1;9(7):1329-1353. eCollection 2019. Am J Cancer Res. 2019. PMID: 31392073 Free PMC article. Review. - Bufadienolides induce p53-mediated apoptosis in esophageal squamous cell carcinoma cells in vitro and in vivo.
Lin S, Lv J, Peng P, Cai C, Deng J, Deng H, Li X, Tang X. Lin S, et al. Oncol Lett. 2018 Feb;15(2):1566-1572. doi: 10.3892/ol.2017.7457. Epub 2017 Nov 21. Oncol Lett. 2018. PMID: 29434851 Free PMC article. - Sann-Joong-Kuey-Jian-Tang induces autophagy in HepG2 cells via regulation of the phosphoinositide-3 kinase/Akt/mammalian target of rapamycin and p38 mitogen-activated protein kinase pathways.
Chuang WL, Su CC, Lin PY, Lin CC, Chen YL. Chuang WL, et al. Mol Med Rep. 2015 Aug;12(2):1677-84. doi: 10.3892/mmr.2015.3573. Epub 2015 Mar 31. Mol Med Rep. 2015. PMID: 25847489 Free PMC article. - Modulation of the Autophagy-lysosomal Pathway in Hepatocellular Carcinoma Using Small Molecules.
Lee YG, Jeon TI. Lee YG, et al. Molecules. 2020 Mar 30;25(7):1580. doi: 10.3390/molecules25071580. Molecules. 2020. PMID: 32235537 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous